2nd International
Brain Technology Conference

March 11-12, Hangar 11, Tel Aviv Port, Israel

Daniel Offen, PhD

Professor of Neuroscience, Rabin Medical Center & Tel Aviv University

Rasheda Ali

Daniel Offen earned his PhD in Molecular Biology at Weizmann Institute of Science and did his post-doctoral studies at the Albert Einstein College of Medicine in N.Y. Prof. Offen heads the Neurology Laboratory at Tel Aviv University in the Department of Human Genetics and Biochemistry. Prof. Offen enjoys an internationally recognized reputation in neuroscience research. He has published over 150 original scientific papers on neurodegenerative diseases and is co-inventor in over a dozen patents. Prof. Offen is a co-founder of several biotechnology companies developing gene and cell therapies for neurological disorders. One of them, Brainstorm Cell Therapeutics, showed efficacy in ALS patients in a Phase II clinical trial.